Furthermore, Nakano et al. reported that exosomal miR-92b demonstrated superior diagnostic performance compared to the traditional biomarker alpha-fetoprotein (AFP) in HCC patients undergoing liver transplantation [86]. The gene discussed is AFP; the disease is hepatocellular carcinoma.